Fidelity Investments
TTHI

Fidelity Investments’s TRANSITION THERAPEUTICS INC (CANADA) TTHI Stock Holding History

Fidelity Investments’s Portfolio TTHI Stock Details TTHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-5,250,356
Closed -$7.65M – 2788
2016
Q2 		$7.65M Sell
5,250,356
-178,151
-3% -$155K ﹤0.01% 2071
2016
Q1 		$6.95M Sell
5,428,507
-16,900
-0.3% -$19.5K ﹤0.01% 2068
2015
Q4 		$10.5M Sell
5,445,407
-52,200
-0.9% -$99.1K ﹤0.01% 1980
2015
Q3 		$9.84M Sell
5,497,607
-29,600
-0.5% -$63K ﹤0.01% 1962
2015
Q2 		$11.6M Sell
5,527,207
-231,728
-4% -$1.62M ﹤0.01% 1951
2015
Q1 		$39.3M Buy
5,758,935
+1,649,500
+40% +$11.4M 0.01% 1441
2014
Q4 		$28M Hold
4,109,435
– – ﹤0.01% 1597
2014
Q3 		$28.4M Hold
4,109,435
– – ﹤0.01% 1581
2014
Q2 		$27.6M Buy
4,109,435
+93,303
+2% +$541K ﹤0.01% 1631
2014
Q1 		$32M Buy
4,016,132
+266,775
+7% +$1.84M ﹤0.01% 1541
2013
Q4 		$21.3M Buy
3,749,357
+250,500
+7% +$1.28M ﹤0.01% 1685
2013
Q3 		$14.3M Buy
3,498,857
+56,000
+2% +$220K ﹤0.01% 1813
2013
Q2 		$11.2M Buy
+3,442,857
New +$9.77M ﹤0.01% 1900

Other funds holding TTHI

HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Fidelity Investments's TTHI Position: Q3 2016 in Review

Fidelity Investments sold out of TRANSITION THERAPEUTICS INC (CANADA) (TTHI) in Q3 2016, closing a stake of 5,250,356 shares — an estimated $7.65M sold.

Fidelity Investments first reported a position in TTHI in Q2 2013 and held it in 13 quarters. The position peaked at $39.3M in Q1 2015. 2 funds tracked by Wall St. Rank hold TTHI as of Q3 2016.

  • Fidelity Investments reported no remaining TRANSITION THERAPEUTICS INC (CANADA) position as of Q3 2016 after selling out during the quarter.
  • Fidelity Investments sold 5,250,356 TRANSITION THERAPEUTICS INC (CANADA) shares in Q3 2016, an estimated $7.65M.
  • Fidelity Investments first reported a position in TRANSITION THERAPEUTICS INC (CANADA) in Q2 2013 and held it in 13 quarters.
  • Fidelity Investments's TRANSITION THERAPEUTICS INC (CANADA) position peaked at $39.3M in Q1 2015.
  • 2 funds tracked by Wall St. Rank held TRANSITION THERAPEUTICS INC (CANADA) as of Q3 2016.

Based on Fidelity Investments's 13F filing for Q3 2016, filed 14 Nov 2016.